Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 2024The Professional Medical JournalOpen Access

Efficacy of topical cyclosporine 0.5% in vernal keratoconjuctivitis.

View Full Paper
Ask AI
Bookmark
Share

Authors

AKAmber KhalidZiauddin HospitalKRKanwal Zehra RizviZiauddin HospitalQQurat‐ul‐AinUniversity of Lahore

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Khalid et al. (2024) studied this question.

synapsesocial.com/papers/68e712b5b6db64358768b85chttps://doi.org/10.29309/tpmj/2024.31.04.8004
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Lirentelimab for severe and chronic forms of allergic conjunctivitis2022 · 49 citations
  2. 2Management of Vernal Keratoconjunctivitis2013 · 122 citations
  3. 3Tear N‐glycomics in vernal and atopic keratoconjunctivitis2021 · 18 citations
  4. 4Alterations in Mucin‐Associated Gene Expression on the Ocular Surface in Active and Stable Stages of Atopic and Vernal Keratoconjunctivitis2021 · 11 citations
  5. 5Ocular surface sphingolipids associate with the refractory nature of vernal keratoconjunctivitis: newer insights in VKC pathogenesis2021 · 10 citations